Synthesis and characterization of novel pH-sensitive nano composites for oral drug delivery

Current Nanoscience

Volumn 8, Issue 5, 2012, Pages 744-748

  Mahkam, Mehrdad ^a,b  

^a AZARBAIJAN SHAHID MADANI UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

4 hydroxybenzoic acid; Nano composites; Naproxen; Oral drug delivery; pH sensitive

Indexed keywords

4-HYDROXYBENZOIC ACIDS; ACYLATING AGENTS; BENZOIC ACID; CARBOXYL GROUPS; EQUILIBRIUM SWELLING; FREE RADICAL COPOLYMERIZATION; FTIR; GRAFT POLYMERIZATION; IN-VITRO; INTESTINAL FLUID; METHACRYLIC ACIDS; NANO SILICA; NANOSILICA PARTICLES; NAPROXENS; ORAL DRUG DELIVERY; ORGANIC FUNCTIONAL GROUPS; PH SENSITIVE; SILICA NANOPARTICLES; VINYL ACETATES; VINYL ESTERS;

CARBOXYLATION; CARBOXYLIC ACIDS; DRUG DELIVERY; ESTERIFICATION; ESTERS; FREE RADICAL POLYMERIZATION; FREE RADICALS; FUNCTIONAL GROUPS;

NANOCOMPOSITES;

4 HYDROXYBENZOIC ACID; CARBOXYL GROUP; METHACRYLIC ACID; NANOCOMPOSITE; NANOPARTICLE; NAPROXEN; SILICON DIOXIDE; VINYL ACETATE;

ARTICLE; CATALYST; DRUG DELIVERY SYSTEM; DRUG RELEASE; EQUILIBRIUM CONSTANT; IN VITRO STUDY; INTESTINE FLUID; PH; POLYMERIZATION; PRIORITY JOURNAL; STOMACH JUICE; SURFACE PROPERTY; SYNTHESIS;

EID: 84867816749     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/157341312802884490     Document Type: Article

References (20)

1. Mahkam, M. New terpolymers as hydrogels for oral protein delivery application. J. Drug Targ., 2009, 17(1), 29-35.
2. Mahkam, M. Starch-based polymeric carriers for oral-insulin delivery. J. Biomed. Mater. Res-A., 2010, 92A (4), 1392-1397.
3. Mahkam, M. Controlled release of biomolecules from pH-sensitive hydrogels prepared by radiation polymerization. J. Bioact. Compat. Polym., 2004, 19(3), 209-220.
4. Mahkam, M. Modified chitosan cross-linked starch polymers for oral insulin delivery. J. Bioact. Compat. Polym., 2010, 25(4), 406-418.
5. Mahkam, M.; Vakhshouri, L. Colon-specific drug delivery behavior of pHresponsive PMAA/ perlite composite. Int. J. Mol. Sci., 2010, 11, 1546-1556.
6. Magdalena Stevanovi, M.; Uskokovi, D. Poly(lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Curr. Nanosci., 2009, 5(1), 1-15.
7. Kresge, C.T.; Leonowicz, M.E.; Roth, W.J.; Vartuli, J.C.; Beck. J.S. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature, 1992, 359, 710-712.
8. De Vos, D.E.; Dams, M.; Sels, B.F.; Jacobs, P.A. Ordered mesoporous and microporous molecular sieves functionalized with transition metal complexes as catalysts for selective organic transformations. Chem. Rev., 2002, 102, 3615-3640.
9. Vinu, A.; Miyahara, M.; Hossain, K.Z.; Takahashi, M.; Balasubramanian, V.V.; Mori, T.; Ariga, K. Lysozyme adsorption onto mesoporous materials: effect of pore geometry and stability of adsorbents. J. Nanosci. Nanotechnol., 2007, 7, 828-832.
10. Salonen, J.; Laitinen, L.; Kaukonen, A.M.; Tuura, J.; Bjorkqvist, M.; Heikkila, T.; Vaha-Heikkila, K.; Hirvonen, J.; Lehto, V.P. Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J. Control. Release, 2005, 108, 362-374.
11. Yu, W.-Y.; Na, Z. Surface modification of nanocarriers for cancer therapy. Curr. Nanosci., 2009, 5, 123-134.
12. Mahkam, M. Synthesis and characterization of pH-sensitive silica nanoparticles for oral-insulin delivery. Curr. Drug. Deliv., 2011, 8, 607-611.
13. United States Pharmacopeia 26/National Formulary 21 US Pharmacopeial Convention, (Rockwille), 1999; pp. 2130-2143.
14. Yang, H.; Henke, E.; Bornscheuer, U.T. The Use of Vinyl Esters Significantly Enhanced Enantioselectivities and Reaction Rates in Lipase-Catalyzed Resolutions of Arylaliphatic Carboxylic Acids. J. Org. Chem., 1999, 64, 1709-1712.
15. Cai, X.Q.; Wang, N.; Lin, X.F. The preparation of polymerizable, optically active non-steroidal anti-inflammatory drugs derivatives by irreversible enzymatic methods. J. Mol. Catal. B. Enzym., 2006, 40, 51-57.
16. Lebold, T.; Jung, C.; Michaelis, J.; Bräuchle, C. Nanostructured silica materials as drug-delivery systems for doxorubicin: single molecule and cellular studies. Nano. Lett., 2009, 9(8), 2877-2883.
17. Lu, J.; Liong, M.; Zink, J.I.; Tamanoi, F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small, 2007, 3(8), 1341-1346.
18. Prokopowicz, M.; Przyjazny, A. Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin. J. Microencapsul., 2007, 24(7), 694-713.
19. Chung, T.H.; Kang, M.S.; Chung, C.J.; Kim, Y. Effects of process parameters on the properties of silicon oxide films using plasma enhanced chemical vapor deposition with tetramethoxysilane. Curr. Appl Phys., 2009, 9, 598-604.
20. Lee, C.H.; Lo, L.W.; Mou, C.Y.; Yang, C.S. Synthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti-inflammatory drug. Adv. Funct. Mater., 2008, 18, 3283-3292.